1Kobayashi S,lde T,Sata M.Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B vires carriers.J Hepatol,2001,34:584-586.
1Yeh CT, Chien RN, Chu CM, et al. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology, 2000,31∶1318-1326.
2Boucher CA,Cammack N,Schipper P,et al.High-level resistance to (-)enantiomeric 2′-deoxy-3′-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type I reverse transcriptase.Antimicrob Agents C
3Kobayashi S,Ide T,Sata M.Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.J Hepatol,2001,34∶584-586.
4Bock CT,Tillmann HL,Torresi J,et al.Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.Gastroenterology,2002,122∶264-273.
5Cane PA, Cook P, Ratcliffe D, et al. Use of real-time PCR and fluorimetry to detect lamivudine resistant-associated mutations in hepatitis B virus. Antimicrob Agents Chemother, 1999,43∶1600-1608.
6Atkins M,Hunt CM,Brown N,et al.Clinical significance of YMDD mutant hepatitis B virus in a large cohort of lamivudine-treated hepatitis B patients(Abstract).Hepatology,1998,28∶319A.
7Nowak M,Bonhoeffer S,Hill A,et al.Viral dynamics in hepatitis B virus infection.Pro Natl Acad Sci USA,1996,93∶4398-4402.
8Niesters HG,Honkoop P,Haagsma EB,et al.Identification of more than one mutation in the hepatitis B virus polymerase arising during prolonged lamivudine treatment.J Infect Dis,1998,177∶1382-1385.
9Back NKT,Nijhuis M,Keulen W,et al.Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.EMBO,1996,15∶4040-4049.